Barclays Starts Avrobio Inc. (AVRO) at Overweight

Barclays analyst Gena Wang initiates coverage on Avrobio Inc. (NASDAQ: AVRO) with a Overweight rating and a price target of $23.00.

For an analyst ratings summary and ratings history on Avrobio Inc. click here. For more ratings news on Avrobio Inc. click here.

Shares of Avrobio Inc. closed at $11.46 yesterday.

You May Also Be Interested In

• UPDATE: B.Riley Reinstates Workhorse Group (WKHS) at Buy, 'Can Deliver Without the Post Office'
• UPDATE: JPMorgan Assumes Palomar Holdings (PLMR) at Overweight
• UPDATE: Goldman Sachs Starts Apellis Pharmaceuticals (APLS) at Buy